▶ 調査レポート

院内肺炎予防の世界市場(~2026年)

• 英文タイトル:Global Hospital-Acquired Pneumonia Prevention Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。院内肺炎予防の世界市場(~2026年) / Global Hospital-Acquired Pneumonia Prevention Market Size, Status and Forecast 2020-2026 / MRC2-11QY12239資料のイメージです。• レポートコード:MRC2-11QY12239
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、90ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療機器・消耗品
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は院内肺炎予防のグローバル市場について調査・分析したレポートです。種類別(オーラルケアキット、歯ブラシ、綿棒、保湿剤、うがい薬、吸引ツール)市場規模、用途別(病院、リハビリテーションセンター、在宅医療)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別院内肺炎予防の競争状況、市場シェア
・世界の院内肺炎予防市場:種類別市場規模 2015年-2020年(オーラルケアキット、歯ブラシ、綿棒、保湿剤、うがい薬、吸引ツール)
・世界の院内肺炎予防市場:種類別市場規模予測 2021年-2026年(オーラルケアキット、歯ブラシ、綿棒、保湿剤、うがい薬、吸引ツール)
・世界の院内肺炎予防市場:用途別市場規模 2015年-2020年(病院、リハビリテーションセンター、在宅医療)
・世界の院内肺炎予防市場:用途別市場規模予測 2021年-2026年(病院、リハビリテーションセンター、在宅医療)
・北米の院内肺炎予防市場分析:米国、カナダ
・ヨーロッパの院内肺炎予防市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの院内肺炎予防市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の院内肺炎予防市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの院内肺炎予防市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Halyard Health、Sage Products LLC、Intersurgical Ltd.、Medline Industries
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcare centers and increases the length of stay in ICU.

Market Analysis and Insights: Global Hospital-Acquired Pneumonia Prevention Market
The global Hospital-Acquired Pneumonia Prevention market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Hospital-Acquired Pneumonia Prevention Scope and Market Size
Hospital-Acquired Pneumonia Prevention market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Acquired Pneumonia Prevention market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Halyard Health
Sage Products LLC
Intersurgical Ltd.
Medline Industries

Market segment by Type, the product can be split into
Oral Care Kit
Toothbrush
Swab
Moisturizer
Mouth Wash
Suction Tools
Market segment by Application, split into
Hospitals
Rehabilitation Centers
Home Care Settings

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hospital-Acquired Pneumonia Prevention Revenue
1.4 Market by Type
1.4.1 Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Care Kit
1.4.3 Toothbrush
1.4.4 Swab
1.4.5 Moisturizer
1.4.6 Mouth Wash
1.4.7 Suction Tools
1.5 Market by Application
1.5.1 Global Hospital-Acquired Pneumonia Prevention Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Rehabilitation Centers
1.5.4 Home Care Settings
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Hospital-Acquired Pneumonia Prevention Market Perspective (2015-2026)
2.2 Global Hospital-Acquired Pneumonia Prevention Growth Trends by Regions
2.2.1 Hospital-Acquired Pneumonia Prevention Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital-Acquired Pneumonia Prevention Historic Market Share by Regions (2015-2020)
2.2.3 Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hospital-Acquired Pneumonia Prevention Market Growth Strategy
2.3.6 Primary Interviews with Key Hospital-Acquired Pneumonia Prevention Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Pneumonia Prevention Players by Market Size
3.1.1 Global Top Hospital-Acquired Pneumonia Prevention Players by Revenue (2015-2020)
3.1.2 Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Players (2015-2020)
3.1.3 Global Hospital-Acquired Pneumonia Prevention Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hospital-Acquired Pneumonia Prevention Market Concentration Ratio
3.2.1 Global Hospital-Acquired Pneumonia Prevention Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Pneumonia Prevention Revenue in 2019
3.3 Hospital-Acquired Pneumonia Prevention Key Players Head office and Area Served
3.4 Key Players Hospital-Acquired Pneumonia Prevention Product Solution and Service
3.5 Date of Enter into Hospital-Acquired Pneumonia Prevention Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hospital-Acquired Pneumonia Prevention Historic Market Size by Type (2015-2020)
4.2 Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020)
5.2 Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Hospital-Acquired Pneumonia Prevention Market Size (2015-2020)
6.2 Hospital-Acquired Pneumonia Prevention Key Players in North America (2019-2020)
6.3 North America Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020)
6.4 North America Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020)

7 Europe
7.1 Europe Hospital-Acquired Pneumonia Prevention Market Size (2015-2020)
7.2 Hospital-Acquired Pneumonia Prevention Key Players in Europe (2019-2020)
7.3 Europe Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020)
7.4 Europe Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020)

8 China
8.1 China Hospital-Acquired Pneumonia Prevention Market Size (2015-2020)
8.2 Hospital-Acquired Pneumonia Prevention Key Players in China (2019-2020)
8.3 China Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020)
8.4 China Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020)

9 Japan
9.1 Japan Hospital-Acquired Pneumonia Prevention Market Size (2015-2020)
9.2 Hospital-Acquired Pneumonia Prevention Key Players in Japan (2019-2020)
9.3 Japan Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020)
9.4 Japan Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Hospital-Acquired Pneumonia Prevention Market Size (2015-2020)
10.2 Hospital-Acquired Pneumonia Prevention Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020)
10.4 Southeast Asia Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020)

11 India
11.1 India Hospital-Acquired Pneumonia Prevention Market Size (2015-2020)
11.2 Hospital-Acquired Pneumonia Prevention Key Players in India (2019-2020)
11.3 India Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020)
11.4 India Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Hospital-Acquired Pneumonia Prevention Market Size (2015-2020)
12.2 Hospital-Acquired Pneumonia Prevention Key Players in Central & South America (2019-2020)
12.3 Central & South America Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020)
12.4 Central & South America Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Halyard Health
13.1.1 Halyard Health Company Details
13.1.2 Halyard Health Business Overview
13.1.3 Halyard Health Hospital-Acquired Pneumonia Prevention Introduction
13.1.4 Halyard Health Revenue in Hospital-Acquired Pneumonia Prevention Business (2015-2020))
13.1.5 Halyard Health Recent Development
13.2 Sage Products LLC
13.2.1 Sage Products LLC Company Details
13.2.2 Sage Products LLC Business Overview
13.2.3 Sage Products LLC Hospital-Acquired Pneumonia Prevention Introduction
13.2.4 Sage Products LLC Revenue in Hospital-Acquired Pneumonia Prevention Business (2015-2020)
13.2.5 Sage Products LLC Recent Development
13.3 Intersurgical Ltd.
13.3.1 Intersurgical Ltd. Company Details
13.3.2 Intersurgical Ltd. Business Overview
13.3.3 Intersurgical Ltd. Hospital-Acquired Pneumonia Prevention Introduction
13.3.4 Intersurgical Ltd. Revenue in Hospital-Acquired Pneumonia Prevention Business (2015-2020)
13.3.5 Intersurgical Ltd. Recent Development
13.4 Medline Industries
13.4.1 Medline Industries Company Details
13.4.2 Medline Industries Business Overview
13.4.3 Medline Industries Hospital-Acquired Pneumonia Prevention Introduction
13.4.4 Medline Industries Revenue in Hospital-Acquired Pneumonia Prevention Business (2015-2020)
13.4.5 Medline Industries Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Hospital-Acquired Pneumonia Prevention Key Market Segments
Table 2. Key Players Covered: Ranking by Hospital-Acquired Pneumonia Prevention Revenue
Table 3. Ranking of Global Top Hospital-Acquired Pneumonia Prevention Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Care Kit
Table 6. Key Players of Toothbrush
Table 7. Key Players of Swab
Table 8. Key Players of Moisturizer
Table 9. Key Players of Mouth Wash
Table 10. Key Players of Suction Tools
Table 11. Global Hospital-Acquired Pneumonia Prevention Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Hospital-Acquired Pneumonia Prevention Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Hospital-Acquired Pneumonia Prevention Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Hospital-Acquired Pneumonia Prevention Market Share by Regions (2015-2020)
Table 15. Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Hospital-Acquired Pneumonia Prevention Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Hospital-Acquired Pneumonia Prevention Market Growth Strategy
Table 21. Main Points Interviewed from Key Hospital-Acquired Pneumonia Prevention Players
Table 22. Global Hospital-Acquired Pneumonia Prevention Revenue by Players (2015-2020) (Million US$)
Table 23. Global Hospital-Acquired Pneumonia Prevention Market Share by Players (2015-2020)
Table 24. Global Top Hospital-Acquired Pneumonia Prevention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Pneumonia Prevention as of 2019)
Table 25. Global Hospital-Acquired Pneumonia Prevention by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Hospital-Acquired Pneumonia Prevention Product Solution and Service
Table 28. Date of Enter into Hospital-Acquired Pneumonia Prevention Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020) (Million US$)
Table 31. Global Hospital-Acquired Pneumonia Prevention Market Size Share by Type (2015-2020)
Table 32. Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Type (2021-2026)
Table 33. Global Hospital-Acquired Pneumonia Prevention Market Size Share by Application (2015-2020)
Table 34. Global Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020) (Million US$)
Table 35. Global Hospital-Acquired Pneumonia Prevention Market Size Share by Application (2021-2026)
Table 36. North America Key Players Hospital-Acquired Pneumonia Prevention Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Hospital-Acquired Pneumonia Prevention Market Share (2019-2020)
Table 38. North America Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020) (Million US$)
Table 39. North America Hospital-Acquired Pneumonia Prevention Market Share by Type (2015-2020)
Table 40. North America Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020) (Million US$)
Table 41. North America Hospital-Acquired Pneumonia Prevention Market Share by Application (2015-2020)
Table 42. Europe Key Players Hospital-Acquired Pneumonia Prevention Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Hospital-Acquired Pneumonia Prevention Market Share (2019-2020)
Table 44. Europe Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Hospital-Acquired Pneumonia Prevention Market Share by Type (2015-2020)
Table 46. Europe Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Hospital-Acquired Pneumonia Prevention Market Share by Application (2015-2020)
Table 48. China Key Players Hospital-Acquired Pneumonia Prevention Revenue (2019-2020) (Million US$)
Table 49. China Key Players Hospital-Acquired Pneumonia Prevention Market Share (2019-2020)
Table 50. China Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020) (Million US$)
Table 51. China Hospital-Acquired Pneumonia Prevention Market Share by Type (2015-2020)
Table 52. China Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020) (Million US$)
Table 53. China Hospital-Acquired Pneumonia Prevention Market Share by Application (2015-2020)
Table 54. Japan Key Players Hospital-Acquired Pneumonia Prevention Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Hospital-Acquired Pneumonia Prevention Market Share (2019-2020)
Table 56. Japan Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Hospital-Acquired Pneumonia Prevention Market Share by Type (2015-2020)
Table 58. Japan Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Hospital-Acquired Pneumonia Prevention Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Hospital-Acquired Pneumonia Prevention Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Hospital-Acquired Pneumonia Prevention Market Share (2019-2020)
Table 62. Southeast Asia Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Hospital-Acquired Pneumonia Prevention Market Share by Type (2015-2020)
Table 64. Southeast Asia Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Hospital-Acquired Pneumonia Prevention Market Share by Application (2015-2020)
Table 66. India Key Players Hospital-Acquired Pneumonia Prevention Revenue (2019-2020) (Million US$)
Table 67. India Key Players Hospital-Acquired Pneumonia Prevention Market Share (2019-2020)
Table 68. India Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020) (Million US$)
Table 69. India Hospital-Acquired Pneumonia Prevention Market Share by Type (2015-2020)
Table 70. India Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020) (Million US$)
Table 71. India Hospital-Acquired Pneumonia Prevention Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Hospital-Acquired Pneumonia Prevention Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Hospital-Acquired Pneumonia Prevention Market Share (2019-2020)
Table 74. Central & South America Hospital-Acquired Pneumonia Prevention Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Hospital-Acquired Pneumonia Prevention Market Share by Type (2015-2020)
Table 76. Central & South America Hospital-Acquired Pneumonia Prevention Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Hospital-Acquired Pneumonia Prevention Market Share by Application (2015-2020)
Table 78. Halyard Health Company Details
Table 79. Halyard Health Business Overview
Table 80. Halyard Health Product
Table 81. Halyard Health Revenue in Hospital-Acquired Pneumonia Prevention Business (2015-2020) (Million US$)
Table 82. Halyard Health Recent Development
Table 83. Sage Products LLC Company Details
Table 84. Sage Products LLC Business Overview
Table 85. Sage Products LLC Product
Table 86. Sage Products LLC Revenue in Hospital-Acquired Pneumonia Prevention Business (2015-2020) (Million US$)
Table 87. Sage Products LLC Recent Development
Table 88. Intersurgical Ltd. Company Details
Table 89. Intersurgical Ltd. Business Overview
Table 90. Intersurgical Ltd. Product
Table 91. Intersurgical Ltd. Revenue in Hospital-Acquired Pneumonia Prevention Business (2015-2020) (Million US$)
Table 92. Intersurgical Ltd. Recent Development
Table 93. Medline Industries Company Details
Table 94. Medline Industries Business Overview
Table 95. Medline Industries Product
Table 96. Medline Industries Revenue in Hospital-Acquired Pneumonia Prevention Business (2015-2020) (Million US$)
Table 97. Medline Industries Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-Acquired Pneumonia Prevention Market Share by Type: 2020 VS 2026
Figure 2. Oral Care Kit Features
Figure 3. Toothbrush Features
Figure 4. Swab Features
Figure 5. Moisturizer Features
Figure 6. Mouth Wash Features
Figure 7. Suction Tools Features
Figure 8. Global Hospital-Acquired Pneumonia Prevention Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Rehabilitation Centers Case Studies
Figure 11. Home Care Settings Case Studies
Figure 12. Hospital-Acquired Pneumonia Prevention Report Years Considered
Figure 13. Global Hospital-Acquired Pneumonia Prevention Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Hospital-Acquired Pneumonia Prevention Market Share by Regions: 2020 VS 2026
Figure 15. Global Hospital-Acquired Pneumonia Prevention Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Hospital-Acquired Pneumonia Prevention Market Share by Players in 2019
Figure 18. Global Top Hospital-Acquired Pneumonia Prevention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Pneumonia Prevention as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Hospital-Acquired Pneumonia Prevention Revenue in 2019
Figure 20. North America Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed